Universe Pharmaceuticals INC
UPC
$2.91
-$0.71-19.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 33.59M | 33.59M | 29.50M | 11.39M | 11.39M |
| Total Receivables | 13.19M | 13.19M | 17.88M | 14.38M | 14.38M |
| Inventory | 4.68M | 4.68M | 2.72M | 3.39M | 3.39M |
| Prepaid Expenses | 883.70K | 883.70K | 1.07M | 4.00M | 4.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.26M | 1.26M | 475.30K | 369.00K | 369.00K |
| Total Current Assets | 53.60M | 53.60M | 51.64M | 33.53M | 33.53M |
|
|
|||||
| Total Current Assets | 53.60M | 53.60M | 51.64M | 33.53M | 33.53M |
| Net Property, Plant & Equipment | 3.58M | 3.58M | 3.57M | 3.52M | 3.52M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 296.80K | 296.80K | 262.90K | 147.70K | 147.70K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.12M | 11.12M | 11.77M | 11.54M | 11.54M |
| Total Assets | 69.30M | 69.30M | 67.95M | 49.43M | 49.43M |
|
|
|||||
| Total Accounts Payable | 1.67M | 1.67M | 4.91M | 7.76M | 7.76M |
| Total Accrued Expenses | 848.70K | 848.70K | 1.23M | 2.90M | 2.90M |
| Short-term Debt | 7.15M | 7.15M | 5.86M | 4.43M | 4.43M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.11M | 2.11M | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.40M | 1.40M | 8.31M | 5.52M | 5.52M |
| Total Other Current Liabilities | 1.40M | 1.40M | 8.31M | 5.52M | 5.52M |
| Total Current Liabilities | 13.17M | 13.17M | 20.31M | 20.61M | 20.61M |
|
|
|||||
| Total Current Liabilities | 13.17M | 13.17M | 20.31M | 20.61M | 20.61M |
| Long-Term Debt | -- | -- | 2.14M | 2.08M | 2.08M |
| Short-term Debt | 7.15M | 7.15M | 5.86M | 4.43M | 4.43M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.17M | 13.17M | 22.45M | 22.69M | 22.69M |
|
|
|||||
| Common Stock & APIC | 69.35M | 69.35M | 54.35M | 29.35M | 29.35M |
| Retained Earnings | -11.40M | -11.40M | -7.73M | -502.60K | -502.60K |
| Treasury Stock & Other | -1.81M | -1.81M | -1.11M | -2.10M | -2.10M |
| Total Common Equity | 56.13M | 56.13M | 45.50M | 26.74M | 26.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 56.13M | 56.13M | 45.50M | 26.74M | 26.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 56.13M | 56.13M | 45.50M | 26.74M | 26.74M |
|
|
|||||